{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:48:53Z","timestamp":1784724533556,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermer\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.enfcli.2020.10.033","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T23:11:23Z","timestamp":1612048283000},"page":"363-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Notificaci\u00f3n de sospechas de reacciones adversas a medicamentos por enfermeras en Espa\u00f1a. Un estudio observacional descriptivo retrospectivo"],"prefix":"10.1016","volume":"31","author":[{"given":"Ver\u00f3nica","family":"Velasco-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Loya-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Navarro-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Sainz-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.enfcli.2020.10.033_bib0140","article-title":"Real Decreto 577\/2013, de 26 de julio, por el que se regula la farmacovigilancia de medicamentos de uso humano","author":"Ministerio de Sanidad, Servicios Sociales e Igualdad","year":"2013","journal-title":"BOE."},{"key":"10.1016\/j.enfcli.2020.10.033_bib0145","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet."},{"key":"10.1016\/j.enfcli.2020.10.033_bib0150","author":"Organizaci\u00f3n Mundial de la Salud (OMS)","year":"2004","journal-title":"Perspectivas pol\u00edticas de la OMS sobre medicamentos. La farmacovigilancia: garant\u00eda de seguridad en el uso de los medicamentos [Internet]"},{"key":"10.1016\/j.enfcli.2020.10.033_bib0155","series-title":"Los primeros 25 a\u00f1os del Sistema Espa\u00f1ol de Farmacovigilancia de Medicamento de Uso Humano","first-page":"31","author":"Manso","year":"2010"},{"key":"10.1016\/j.enfcli.2020.10.033_bib0160","first-page":"3","article-title":"Enfermer\u00eda y Farmacovigilancia","volume":"22","author":"Salcedo de Diego","year":"2015","journal-title":"Bolet\u00edn Informativo del Centro de Farmacovigilancia de la Comunidad de Madrid [Internet]"},{"key":"10.1016\/j.enfcli.2020.10.033_bib0165","author":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","year":"2016","journal-title":"Informaci\u00f3n para las notificaciones de sospechas de reacciones adversas a medicamentos por parte de ciudadanos [Internet]"},{"key":"10.1016\/j.enfcli.2020.10.033_bib0170","author":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","year":"2016","journal-title":"Medicamentos sujetos a seguimiento adicional [Internet]"},{"key":"10.1016\/j.enfcli.2020.10.033_bib0175","author":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","year":"2015","journal-title":"\u00bfQu\u00e9 es el Sistema Espa\u00f1ol de Farmacovigilancia de Medicamentos de Uso Humano (SEFV-H)? [Internet]"},{"key":"10.1016\/j.enfcli.2020.10.033_bib0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/jonm.12310","article-title":"Factors that condition the spontaneous reporting of adverse drug reactions among nurses: An integrative review","volume":"24","author":"De Angelis","year":"2016","journal-title":"J Nurs Manag. [Internet]"},{"key":"10.1016\/j.enfcli.2020.10.033_bib0185","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/jonm.12003","article-title":"Nurses\u2019 spontaneous reporting of adverse drug reactions: Expert review of routine reports","volume":"22","author":"Mendes","year":"2014","journal-title":"J Nurs Manag. [Internet]"},{"key":"10.1016\/j.enfcli.2020.10.033_bib0190","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(03)13043-7","article-title":"Reporting of adverse drug reactions by nurses","volume":"361","author":"Morrison-Griffiths","year":"2003","journal-title":"Lancet. [Internet]"},{"key":"10.1016\/j.enfcli.2020.10.033_bib0195","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00228-015-1839-6","article-title":"The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses\u2019 reporting","volume":"71","author":"Karlsson","year":"2015","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.enfcli.2020.10.033_bib0200","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/pds.3225","article-title":"Adverse drug reaction reporting by nurses: analysis of Italian pharmacovigilance database","volume":"21","author":"Conforti","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf [Internet]."},{"issue":"n\u00fam. 102","key":"10.1016\/j.enfcli.2020.10.033_bib0205","article-title":"Ley 14\/1986, de 25 de abril, General de Sanidad","author":"Jefatura del Estado","year":"1986","journal-title":"BOE."},{"issue":"n\u00fam. 178","key":"10.1016\/j.enfcli.2020.10.033_bib0210","article-title":"Ley 29\/2006, de 26 de julio, de garant\u00edas y uso racional de los medicamentos y productos sanitarios","author":"Jefatura del Estado","year":"2006","journal-title":"BOE."},{"issue":"n\u00fam. 177","key":"10.1016\/j.enfcli.2020.10.033_bib0215","article-title":"Real Decreto Legislativo 1\/2015, de 24 de julio, por el que se aprueba el texto refundido de la Ley de garant\u00edas y uso racional de los medicamentos y productos sanitarios","author":"Ministerio de Sanidad, Servicios Sociales e Igualdad","year":"2015","journal-title":"BOE."},{"key":"10.1016\/j.enfcli.2020.10.033_bib0220","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.therap.2016.02.007","article-title":"Pharmacovigilance implemented by patients: A necessity in the 21st century","volume":"71","author":"Lafond","year":"2016","journal-title":"Therapie [Internet]."},{"key":"10.1016\/j.enfcli.2020.10.033_bib0225","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2753.2003.00456.x","article-title":"Factors that influence spontaneous reporting of adverse drug reactions: A model centralized in the medical professional","volume":"10","author":"Herdeiro","year":"2004","journal-title":"J Eval Clin Pract."},{"key":"10.1016\/j.enfcli.2020.10.033_bib0230","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/nhs.12355","article-title":"Nurse prescribing in Spain: The law and the curriculum","volume":"19","author":"Romero-Collado","year":"2017","journal-title":"Nurs Health Sci [Internet]."},{"key":"10.1016\/j.enfcli.2020.10.033_bib0235","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00228-020-02894-0","article-title":"Quantity is not enough: completeness of suspected adverse drug reaction reports in Spain\u2014differences between regional pharmacovigilance centres and pharmaceutical industry","volume":"76","author":"Fernandez-Fernandez","year":"2020","journal-title":"Eur J Clin Pharmacol [Internet]."},{"key":"10.1016\/j.enfcli.2020.10.033_bib0240","first-page":"178","article-title":"Broncoespasmo y flushing tras la vacunaci\u00f3n con neumococo polisac\u00e1rida de 23 serotipos en pacientes cr\u00f3nicos","volume":"32","author":"Fern\u00e1ndez-Prada","year":"2019","journal-title":"Rev Esp Quimioter [Internet]."},{"key":"10.1016\/j.enfcli.2020.10.033_bib0245","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1130-8621(07)71824-7","article-title":"Role of nurses from Extremadura in the Spanish drug surveillance system (2000-2005)","volume":"17","author":"Giraldo-Matamoros","year":"2016","journal-title":"Enferm Clin [Internet]."},{"key":"10.1016\/j.enfcli.2020.10.033_bib0250","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","article-title":"Determinants of under-reporting of adverse drug reactions: a systematic review","volume":"32","author":"L\u00f3pez-Gonzalez","year":"2009","journal-title":"Drug Saf [Internet]."},{"key":"10.1016\/j.enfcli.2020.10.033_bib0255","series-title":"Aspectos psicol\u00f3gicos de los cuidados de enfermer\u00eda en el paciente anciano [Trabajo fin de grado]","first-page":"1","author":"Garc\u00eda Cancela","year":"2016"},{"key":"10.1016\/j.enfcli.2020.10.033_bib0260","first-page":"10","article-title":"Papel de las enfermeras en la notificaci\u00f3n de reacciones adversas medicamentosas en Castilla y Le\u00f3n (Espa\u00f1a)","volume":"3","author":"Velasco Gonz\u00e1lez","year":"2013","journal-title":"Rev Iberoam Educ Investi Enferm."},{"key":"10.1016\/j.enfcli.2020.10.033_bib0265","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00228-017-2225-3","article-title":"Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis","volume":"73","author":"Oscanoa","year":"2017","journal-title":"Eur J Clin Pharmacol [Internet]."},{"issue":"n\u00fam. 256","key":"10.1016\/j.enfcli.2020.10.033_bib0270","author":"Ministerio de Sanidad, Servicios Sociales e Igualdad","year":"2018","journal-title":"BOE."}],"container-title":["Enfermer\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130862120305349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130862120305349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:23:26Z","timestamp":1761107006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130862120305349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1130862120305349"],"URL":"https:\/\/doi.org\/10.1016\/j.enfcli.2020.10.033","relation":{},"ISSN":["1130-8621"],"issn-type":[{"value":"1130-8621","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Notificaci\u00f3n de sospechas de reacciones adversas a medicamentos por enfermeras en Espa\u00f1a. Un estudio observacional descriptivo retrospectivo","name":"articletitle","label":"Article Title"},{"value":"Enfermer\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.enfcli.2020.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}